Differentiating systemic lupus erythematosus from other diseases: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(25 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
 
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Systemic_lupus_erythematosus]]
__NOTOC__
{{CMG}}; {{AE}} {{MIR}}
{{Systemic lupus erythematosus}}
{{CMG}}; {{AE}}{{MIR}}
==Overview==
==Overview==
Systemic lupus erythematosus (SLE) must be differentiated from other diseases that cause skin rash, [[arthritis]], positive [[autoimmune]] serology, weight loss, [[Fever|fevers]] and [[chronic pain]], such as [[rheumatoid arthritis]](RA), [[mixed connective tissue disease]] (MCTD), [[systemic sclerosis]] (SSc), [[dermatomyositis]] (DM), [[polymyositis]](PM), and other [[autoimmune diseases]].
Systemic lupus erythematosus (SLE) must be differentiated from other diseases that cause skin [[rash]], [[arthritis]], positive [[autoimmune]] serology, [[weight loss]], [[Fever|fevers]] and [[chronic pain]], such as [[rheumatoid arthritis]] (RA), [[mixed connective tissue disease]] (MCTD), [[systemic sclerosis]] (SSc), [[dermatomyositis]] (DM), [[polymyositis]] (PM), and other [[autoimmune diseases]].


==Differentiating systemic lupus erythematosus from other diseases==
==Differentiating systemic lupus erythematosus from other diseases==
Systemic lupus erythematosus (SLE) must be differentiated from other diseases that cause skin rash, [[arthritis]], positive [[autoimmune]] serology, weight loss, [[Fever|fevers]] and [[chronic pain]], such as [[rheumatoid arthritis]](RA), [[mixed connective tissue disease]] (MCTD), [[systemic sclerosis]] (SSc), [[dermatomyositis]] (DM), [[polymyositis]](PM), and other autoimmune diseases.  
Systemic lupus erythematosus (SLE) must be differentiated from other diseases that cause skin [[rash]], [[arthritis]], positive [[autoimmune]] serology, [[weight loss]], [[Fever|fevers]] and [[chronic pain]], such as [[rheumatoid arthritis]] (RA), [[mixed connective tissue disease]] (MCTD), [[systemic sclerosis]] (SSc), [[dermatomyositis]] (DM), [[polymyositis]] (PM), and other [[autoimmune diseases]].  


===== Differetiating SLE from other diseases that cause [[arthritis]] and [[rash]] =====
===== Differentiating SLE from other diseases that may cause [[arthritis]] and [[rash]]=====
<span style="font-size:85%">'''Abbreviations:'''
'''ANA:''' [[Anti-nuclear antibody|Antinuclear antibody]], '''RF:''' [[Rheumatoid factor]], '''Anti-CCp:''' [[Anti-citrullinated protein antibody|Anti-cyclic citrullinated protein antibody]], '''Anti U1RNP:''' Anti-U1 ribonucleoprotein antibodies, '''Anti Sm:''' Anti-Sm antibodies, '''Anti Ro:''' Anti Ro antibody also called anti-Sjögren's-syndrome-related antigen A antibody, '''Anti-dsDNA:''' [[Anti-dsDNA antbodies|Anti-double stranded DNA]].
</span>
<br>
<small>(Up arrows represent higher amounts and down arrows represent lower amounts)</small>
<small>
{| class="wikitable"
{| class="wikitable"
! colspan="2" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |n
! colspan="2" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Disease
! colspan="5" align="center" style="background:#4479BA; color: #FFFFFF;" |Arthritis
! colspan="5" align="center" style="background:#4479BA; color: #FFFFFF;" |Arthritis
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" |Auto-antibodies
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" |Auto-antibodies
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Raynaud phenamon
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Raynaud phenomenon
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Rash pattern
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Rash pattern
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Distinguishing/specific features
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Distinguishing/specific features
|-
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" |Polyarthritis
! align="center" style="background:#4479BA; color: #FFFFFF;" |Polyarthritis
Line 27: Line 31:
! align="center" style="background:#4479BA; color: #FFFFFF;" |RF
! align="center" style="background:#4479BA; color: #FFFFFF;" |RF
! align="center" style="background:#4479BA; color: #FFFFFF;" |Anti-CCp
! align="center" style="background:#4479BA; color: #FFFFFF;" |Anti-CCp
! align="center" style="background:#4479BA; color: #FFFFFF;" |anti U1RNP
! align="center" style="background:#4479BA; color: #FFFFFF;" |Anti U1RNP
! align="center" style="background:#4479BA; color: #FFFFFF;" |AntiSm
! align="center" style="background:#4479BA; color: #FFFFFF;" |Anti Sm
! align="center" style="background:#4479BA; color: #FFFFFF;" |AntiRo
! align="center" style="background:#4479BA; color: #FFFFFF;" |Anti Ro
! align="center" style="background:#4479BA; color: #FFFFFF;" |Anti-dsDNA
! align="center" style="background:#4479BA; color: #FFFFFF;" |Anti-dsDNA
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Systemic lupus erythematosus]]
| colspan="2" align="center" style="background:#DCDCDC;" |[[Systemic lupus erythematosus]]<ref name="pmid25074031">{{cite journal |vauthors=Ehmke TA, Cherian JJ, Wu ES, Jauregui JJ, Banerjee S, Mont MA |title=Treatment of osteonecrosis in systemic lupus erythematosus: a review |journal=Curr Rheumatol Rep |volume=16 |issue=9 |pages=441 |year=2014 |pmid=25074031 |doi=10.1007/s11926-014-0441-8 |url=}}</ref>
|
| align="center" |<nowiki>+</nowiki>
|
| align="center" |<nowiki>+</nowiki>
|
| align="center" |<nowiki>+</nowiki>
|
| align="center" |<nowiki>-</nowiki>
|Small joints
| align="center" |Small joints
|
| align="center" |↑
|
| align="center" |<nowiki>-</nowiki>
|
| align="center" |<nowiki>-</nowiki>
|
| align="center" | -
|
| align="center" |↑
|
| align="center" |↑
|
| align="center" | -
|
| align="center" |<nowiki>+</nowiki>
|
|[[Malar rash]] and [[photosensitivity]]
|
|
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Rheumatoid arthritis]] ([[Rheumatoid arthritis|RA]])
| colspan="2" align="center" style="background:#DCDCDC;" |[[Rheumatoid arthritis]] ([[Rheumatoid arthritis|RA]])<ref name="pmid11567728">{{cite journal |vauthors=Lee DM, Weinblatt ME |title=Rheumatoid arthritis |journal=Lancet |volume=358 |issue=9285 |pages=903–11 |year=2001 |pmid=11567728 |doi=10.1016/S0140-6736(01)06075-5 |url=}}</ref>
| +
| align="center" | +
| +
| align="center" | +
| +
| align="center" | +
| +
| align="center" | +
|Small and large joints
| align="center" |Small and large joints
|
| align="center" |<nowiki>-</nowiki>
|↑↑
| align="center" |↑↑
|↑↑
| align="center" |↑↑
|
| align="center" |<nowiki>-</nowiki>
|
| align="center" |<nowiki>-</nowiki>
|
| align="center" | -
|
| align="center" | -
| +
| align="center" | +
|
|[[Subcutaneous]] [[nodules]]
*
|Erosive [[arthropathy]]
|
*
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |Rhupus
| colspan="2" align="center" style="background:#DCDCDC;" |Rhupus<ref name="pmid3382309">{{cite journal |vauthors=Panush RS, Edwards NL, Longley S, Webster E |title='Rhupus' syndrome |journal=Arch. Intern. Med. |volume=148 |issue=7 |pages=1633–6 |year=1988 |pmid=3382309 |doi= |url=}}</ref>
| +
| align="center" | +
| +
| align="center" | +
| +
| align="center" | +
| +
| align="center" | +
|Small and large joints
| align="center" |Small and large joints
|↑
| align="center" |↑
|↑
| align="center" |↑
|↑
| align="center" |↑
|↑
| align="center" |↑
|↑
| align="center" |↑
|
| align="center" |<nowiki>-</nowiki>
|↑
| align="center" |↑
| +
| align="center" | +
|
|[[Malar rash]] and [[photosensitivity]]
* Patients with overlapping features of both SLE and [[Rheumatoid arthritis|RA]]
|Erosive [[arthropathy]]
* Serologies consistent with both SLE and [[Rheumatoid arthritis|RA]]
|
* Erosive [[arthropathy]] that is atypical for SLE
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Mixed connective tissue disease]] (MCTD)<ref name="pmid21959290">{{cite journal |vauthors=Cappelli S, Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radić M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirják L, Damjanov N, Rednic S, Matucci Cerinic M |title="To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity |journal=Semin. Arthritis Rheum. |volume=41 |issue=4 |pages=589–98 |year=2012 |pmid=21959290 |doi=10.1016/j.semarthrit.2011.07.010 |url=}}</ref>
| colspan="2" align="center" style="background:#DCDCDC;" |[[Mixed connective tissue disease]] (MCTD)<ref name="pmid21959290">{{cite journal |vauthors=Cappelli S, Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radić M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirják L, Damjanov N, Rednic S, Matucci Cerinic M |title="To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity |journal=Semin. Arthritis Rheum. |volume=41 |issue=4 |pages=589–98 |year=2012 |pmid=21959290 |doi=10.1016/j.semarthrit.2011.07.010 |url=}}</ref>
|
| align="center" |<nowiki>-</nowiki>
|
| align="center" | -
|
| align="center" | -
| +
| align="center" | +
|Small and large joints
| align="center" |Small and large joints
|
| align="center" |<nowiki>-</nowiki>
|↑↑
| align="center" |↑↑
|↑
| align="center" |↑
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
| +
| align="center" | +
|
|Cutaneous eruptions, [[Gottron's papules]], photodistributed [[erythema]], [[Poikiloderma of civatte|poikiloderma]], and [[calcinosis cutis]]
* A mix disease with overlapping features of SLE, [[systemic sclerosis]] (SSc), and [[polymyositis]] (PM)
|Overlapping features of SLE, [[systemic sclerosis]] (SSc), and [[polymyositis]] (PM) that lead to more than one diagnosis
* [[Antibodies]] against U1 ribonucleoprotein (RNP)
|
*
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Undifferentiated connective tissue disease]] (UCTD)
| colspan="2" align="center" style="background:#DCDCDC;" |[[Undifferentiated connective tissue disease]] (UCTD)<ref name="pmid1757934">{{cite journal |vauthors=Alarcón GS, Williams GV, Singer JZ, Steen VD, Clegg DO, Paulus HE, Billingsley LM, Luggen ME, Polisson RP, Willkens RF |title=Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease |journal=J. Rheumatol. |volume=18 |issue=9 |pages=1332–9 |year=1991 |pmid=1757934 |doi= |url=}}</ref>
| +
| align="center" | +
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|Small and large joints
| align="center" |Lower extremity
|↑
| align="center" |↑
|↑
| align="center" |↑
|
| align="center" | -
|
| align="center" | -
|↑
| align="center" |↑
|
| align="center" | -
|
| align="center" | -
| +
| align="center" | +
|
|[[Erythematous]] [[macules]], patches, or [[papules]] with delicate scale
* erythematous macules, patches, or papules with delicate scale
|Multiple connective tissue diseases with no enough criteria for a single diagnosis
* mostly in lower extremities
|
* sclerodactyly
* telangiectasias
* calcinosis
* malignant hypertension
* acute renal failure
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |[[Systemic sclerosis]] (SSc)
| colspan="2" align="center" style="background:#DCDCDC;" |[[Systemic sclerosis]] (SSc)<ref name="pmid3361530">{{cite journal |vauthors=LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F |title=Scleroderma (systemic sclerosis): classification, subsets and pathogenesis |journal=J. Rheumatol. |volume=15 |issue=2 |pages=202–5 |year=1988 |pmid=3361530 |doi= |url=}}</ref>
|<nowiki>+/-</nowiki>
| align="center" |<nowiki>+/-</nowiki>
|<nowiki>+</nowiki>
| align="center" |<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| align="center" |<nowiki>+</nowiki>
|<nowiki>+/-</nowiki>
| align="center" |<nowiki>+/-</nowiki>
|
| align="center" |Lower extremity
|↑↑
| align="center" |↑↑
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|↑
| align="center" |↑
|
| align="center" | -
|↑
| align="center" |↑
| +
| align="center" | +
|
|[[Hyperkeratosis]], [[edema]], and [[erythema]]
* skin thickening and hardening
|[[Sclerodactyly]], [[Telangiectasias]], [[Calcinosis]], [[Malignant hypertension]], [[acute renal failure]]
* Edematous swelling and erythema
|
* [[Sclerodactyly]]
* [[Telangiectasias]]
* [[Calcinosis]]
* [[Malignant hypertension]]
* [[acute renal failure]]
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |Sjögren’s syndrome
| colspan="2" align="center" style="background:#DCDCDC;" |[[Sjögren’s syndrome]]<ref name="pmid15485020">{{cite journal |vauthors=Roguedas AM, Misery L, Sassolas B, Le Masson G, Pennec YL, Youinou P |title=Cutaneous manifestations of primary Sjögren's syndrome are underestimated |journal=Clin. Exp. Rheumatol. |volume=22 |issue=5 |pages=632–6 |year=2004 |pmid=15485020 |doi= |url=}}</ref>
15485020
| align="center" |<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
| align="center" |<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
| align="center" | -
|
| align="center" | -
|
| align="center" |[[Lower extremity]], axiallary creases
|Lower extremity
| align="center" |↑
and
| align="center" | -
 
| align="center" | -
axiallary creases
| align="center" | -
|↑
| align="center" |↑
|
| align="center" |↑
|
| align="center" | -
|
| align="center" | -
|
|[[Xerosis]], scaly skin, annular [[erythema]]
|↑
|
|
|
* Xerosis
* Scaly skin
* Annular erythema


|
|[[Keratoconjunctivitis sicca]]
* [[Keratoconjunctivitis sicca]]
* [[Xerostomia]]
|-
|-
| rowspan="3" align="center" style="background:#DCDCDC;" |Vasculitis
| rowspan="3" align="center" style="background:#DCDCDC;" |Vasculitis
| align="center" style="background:#DCDCDC;" |Giant cell
| align="center" style="background:#DCDCDC;" |[[Temporal arteritis]]<ref name="pmid17031245">{{cite journal |vauthors=Bablekos GD, Michaelides SA, Karachalios GN, Nicolaou IN, Batistatou AK, Charalabopoulos KA |title=Pericardial involvement as an atypical manifestation of giant cell arteritis: report of a clinical case and literature review |journal=Am. J. Med. Sci. |volume=332 |issue=4 |pages=198–204 |year=2006 |pmid=17031245 |doi= |url=}}</ref>
|
| align="center" | -
|<nowiki>+</nowiki>
| align="center" |<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| align="center" |<nowiki>+</nowiki>
|
| align="center" | -
|
| align="center" |Distal extremity
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
| rowspan="3"|
| rowspan="3" align="center" | -
|
|Rare
* Rare
|Involvement of cranial branches of arteries, visual loss
|
* cranial branches of arteries
* visual loss
|-
|-
| align="center" style="background:#DCDCDC;" |[[Takayasu's arteritis|Takayasu]]
| align="center" style="background:#DCDCDC;" |[[Takayasu's arteritis|Takayasu]]<ref name="pmid12655">{{cite journal |vauthors=Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE |title=Takayasu's arteritis. Clinical study of 107 cases |journal=Am. Heart J. |volume=93 |issue=1 |pages=94–103 |year=1977 |pmid=12655 |doi= |url=}}</ref>
|
| align="center" |<nowiki>-</nowiki>
| +/-
| align="center" | +/-
| +/-
| align="center" | +/-
|
| align="center" | -
|
| align="center" |Transient extremity
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
|[[Erythema nodosum]], [[pyoderma gangrenosum]]
* Erythema nodosum
|Absent or weak peripheral pulse
* Pyoderma gangrenosum
|
|-
|-
| align="center" style="background:#DCDCDC;" |[[Polyarteritis nodosa|Poly-arteritis nodosa]]
| align="center" style="background:#DCDCDC;" |[[Polyarteritis nodosa|Poly-arteritis nodosa]]<ref name="pmid20112401">{{cite journal |vauthors=Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, Bienvenu B, Mouthon L, Guillevin L |title=Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database |journal=Arthritis Rheum. |volume=62 |issue=2 |pages=616–26 |year=2010 |pmid=20112401 |doi=10.1002/art.27240 |url=}}</ref>
|
| align="center" | -
| +/-
| align="center" | +/-
|
| align="center" | -
|
| align="center" | -
|
| align="center" |General and mild
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
|[[Tenderness|Tender]] [[Erythematous rash|erythematous nodules]], [[purpura]], [[livedo reticularis]], [[bullous]] or [[Vesicular|vesicular eruption]]
* tender erythematous nodules
|[[Testicular pain]] or [[tenderness]] and [[neuropathies]]
* Purpura
* Livedo reticularis
* Bullous or vesicular eruption
|
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |Behçet’s syndrome
| colspan="2" align="center" style="background:#DCDCDC;" |[[Behçet's Syndrome|Behçet’s syndrome]]<ref name="pmid11760398">{{cite journal |vauthors=Tunç R, Uluhan A, Melikoğlu M, Ozyazgan Y, Ozdoğan H, Yazici H |title=A reassessment of the International Study Group criteria for the diagnosis (classification) of Behçet's syndrome |journal=Clin. Exp. Rheumatol. |volume=19 |issue=5 Suppl 24 |pages=S45–7 |year=2001 |pmid=11760398 |doi= |url=}}</ref>
|<nowiki>+/-</nowiki>
| align="center" |<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
| align="center" |<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
| align="center" |<nowiki>+/-</nowiki>
|
| align="center" | -
|
| align="center" |medium and large joints
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
|Recurrent and usually painful [[mucocutaneous]] ulcers, [[Acneiform eruption|acneiform]] [[lesions]], papulo-vesiculo-[[Pustular rash|pustular]] eruptions, superficial [[thrombophlebitis]]
* acneiform lesions
|Male dominancy
* Papulo-vesiculo-pustular eruptions
* Superficial thrombophlebitis
|
* Male dominancy
* [[ANA]]-negative
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |Kikuchi’s disease
| colspan="2" align="center" style="background:#DCDCDC;" |[[Kikuchi's Disease|Kikuchi’s disease]]<ref name="pmid16538388">{{cite journal |vauthors=Kucukardali Y, Solmazgul E, Kunter E, Oncul O, Yildirim S, Kaplan M |title=Kikuchi-Fujimoto Disease: analysis of 244 cases |journal=Clin. Rheumatol. |volume=26 |issue=1 |pages=50–4 |year=2007 |pmid=16538388 |doi=10.1007/s10067-006-0230-5 |url=}}</ref>
|
| align="center" | -
|<nowiki>+/-</nowiki>
| align="center" |<nowiki>+/-</nowiki>
|
| align="center" | -
|
| align="center" | -
|
| align="center" |medium and large joints
|↑/↓
| align="center" |↑/↓
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
|Transient skin [[rashes]], [[malar rash]], [[Macule|erythematous macules]], patches, [[papules]], or [[plaques]]
* Transient skin rashes
|May be associated with SLE
* Malar rash
 
* Erythematous macules, patches, papules, or plaques
|
* May be associated with SLE
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |Serum sickness
| colspan="2" align="center" style="background:#DCDCDC;" |[[Serum sickness]]<ref name="pmid3564980">{{cite journal |vauthors=Kunnamo I, Kallio P, Pelkonen P, Viander M |title=Serum-sickness-like disease is a common cause of acute arthritis in children |journal=Acta Paediatr Scand |volume=75 |issue=6 |pages=964–9 |year=1986 |pmid=3564980 |doi= |url=}}</ref>
|<nowiki>+/-</nowiki>
| align="center" | +
|<nowiki>+</nowiki>
| align="center" |<nowiki>+</nowiki>
|<nowiki>+/-</nowiki>
| align="center" |<nowiki>+/-</nowiki>
|
| align="center" | -
|
| align="center" |General
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
|[[Pruritic disorders|Pruritic rash]], [[urticaria]] and/or serpiginous [[Rash|macular rash]]
* pruritic rash
|Self-limited
* urticarial and/or serpiginous macular rash
|
* Negative [[Antinuclear antibodies|ANA]]
* Self-limited
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |Psoriatic arthritis
| colspan="2" align="center" style="background:#DCDCDC;" |[[Psoriatic arthritis]]<ref name="pmid8076388">{{cite journal |vauthors=Oriente P, Biondi-Oriente C, Scarpa R |title=Psoriatic arthritis. Clinical manifestations |journal=Baillieres Clin Rheumatol |volume=8 |issue=2 |pages=277–94 |year=1994 |pmid=8076388 |doi= |url=}}</ref>
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|Small and large joints
| align="center" |Small and large joints
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
|[[Psoriasis]] and [[onychodystrophy]]
|
|[[Dactylitis]] (sausage digits)
|-
|-
| colspan="2" align="center" style="background:#DCDCDC;" |Human [[parvovirus]] B19 infection
| colspan="2" align="center" style="background:#DCDCDC;" |[[Parvovirus B19|Human parvovirus B19 infection]]<ref name="pmid17384979">{{cite journal |vauthors=Kaufmann J, Buccola JM, Stead W, Rowley C, Wong M, Bates CK |title=Secondary symptomatic parvovirus B19 infection in a healthy adult |journal=J Gen Intern Med |volume=22 |issue=6 |pages=877–8 |year=2007 |pmid=17384979 |pmc=2219874 |doi=10.1007/s11606-007-0173-9 |url=}}</ref>
|<nowiki>+</nowiki>
| align="center" |<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| align="center" |<nowiki>+</nowiki>
|
| align="center" | -
|
| align="center" | -
|Small joints
| align="center" |Small joints
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
| align="center" | -
|
|[[Erythematous rash|Erythematous rashes]]
*
|Rare in adults, [[Fifth disease|fifth's disease]] in children
|
|}</small>
* Flu-like symptoms
* Hematologic abnormalities such as [[leukopenia]] and [[thrombocytopenia]]
|}


==References==
==References==

Latest revision as of 21:06, 20 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]

Overview

Systemic lupus erythematosus (SLE) must be differentiated from other diseases that cause skin rash, arthritis, positive autoimmune serology, weight loss, fevers and chronic pain, such as rheumatoid arthritis (RA), mixed connective tissue disease (MCTD), systemic sclerosis (SSc), dermatomyositis (DM), polymyositis (PM), and other autoimmune diseases.

Differentiating systemic lupus erythematosus from other diseases

Systemic lupus erythematosus (SLE) must be differentiated from other diseases that cause skin rash, arthritis, positive autoimmune serology, weight loss, fevers and chronic pain, such as rheumatoid arthritis (RA), mixed connective tissue disease (MCTD), systemic sclerosis (SSc), dermatomyositis (DM), polymyositis (PM), and other autoimmune diseases.

Differentiating SLE from other diseases that may cause arthritis and rash

Abbreviations: ANA: Antinuclear antibody, RF: Rheumatoid factor, Anti-CCp: Anti-cyclic citrullinated protein antibody, Anti U1RNP: Anti-U1 ribonucleoprotein antibodies, Anti Sm: Anti-Sm antibodies, Anti Ro: Anti Ro antibody also called anti-Sjögren's-syndrome-related antigen A antibody, Anti-dsDNA: Anti-double stranded DNA.
(Up arrows represent higher amounts and down arrows represent lower amounts)

Disease Arthritis Auto-antibodies Raynaud phenomenon Rash pattern Distinguishing/specific features
Polyarthritis Tenderness Edema Deformity /Erosion Pattern ANA RF Anti-CCp Anti U1RNP Anti Sm Anti Ro Anti-dsDNA
Systemic lupus erythematosus[1] + + + - Small joints ↑ - - - ↑ ↑ - + Malar rash and photosensitivity
Rheumatoid arthritis (RA)[2] + + + + Small and large joints - ↑↑ ↑↑ - - - - + Subcutaneous nodules Erosive arthropathy
Rhupus[3] + + + + Small and large joints ↑ ↑ ↑ ↑ ↑ - ↑ + Malar rash and photosensitivity Erosive arthropathy
Mixed connective tissue disease (MCTD)[4] - - - + Small and large joints - ↑↑ ↑ - - - - + Cutaneous eruptions, Gottron's papules, photodistributed erythema, poikiloderma, and calcinosis cutis Overlapping features of SLE, systemic sclerosis (SSc), and polymyositis (PM) that lead to more than one diagnosis
Undifferentiated connective tissue disease (UCTD)[5] + - - - Lower extremity ↑ ↑ - - ↑ - - + Erythematous macules, patches, or papules with delicate scale Multiple connective tissue diseases with no enough criteria for a single diagnosis
Systemic sclerosis (SSc)[6] +/- + + +/- Lower extremity ↑↑ - - - ↑ - ↑ + Hyperkeratosis, edema, and erythema Sclerodactyly, Telangiectasias, Calcinosis, Malignant hypertension, acute renal failure
Sjögren’s syndrome[7] +/- +/- - - Lower extremity, axiallary creases ↑ - - - ↑ ↑ - - Xerosis, scaly skin, annular erythema Keratoconjunctivitis sicca
Vasculitis Temporal arteritis[8] - + + - Distal extremity - - - - - - - - Rare Involvement of cranial branches of arteries, visual loss
Takayasu[9] - +/- +/- - Transient extremity - - - - - - - Erythema nodosum, pyoderma gangrenosum Absent or weak peripheral pulse
Poly-arteritis nodosa[10] - +/- - - General and mild - - - - - - - Tender erythematous nodules, purpura, livedo reticularis, bullous or vesicular eruption Testicular pain or tenderness and neuropathies
Behçet’s syndrome[11] +/- +/- +/- - medium and large joints - - - - - - - - Recurrent and usually painful mucocutaneous ulcers, acneiform lesions, papulo-vesiculo-pustular eruptions, superficial thrombophlebitis Male dominancy
Kikuchi’s disease[12] - +/- - - medium and large joints ↑/↓ - - - - - - - Transient skin rashes, malar rash, erythematous macules, patches, papules, or plaques May be associated with SLE
Serum sickness[13] + + +/- - General - - - - - - - - Pruritic rash, urticaria and/or serpiginous macular rash Self-limited
Psoriatic arthritis[14] - - - - Small and large joints - - - - - - - - Psoriasis and onychodystrophy Dactylitis (sausage digits)
Human parvovirus B19 infection[15] + + - - Small joints - - - - - - - - Erythematous rashes Rare in adults, fifth's disease in children

References

  1. ↑ Ehmke TA, Cherian JJ, Wu ES, Jauregui JJ, Banerjee S, Mont MA (2014). "Treatment of osteonecrosis in systemic lupus erythematosus: a review". Curr Rheumatol Rep. 16 (9): 441. doi:10.1007/s11926-014-0441-8. PMID 25074031.
  2. ↑ Lee DM, Weinblatt ME (2001). "Rheumatoid arthritis". Lancet. 358 (9285): 903–11. doi:10.1016/S0140-6736(01)06075-5. PMID 11567728.
  3. ↑ Panush RS, Edwards NL, Longley S, Webster E (1988). "'Rhupus' syndrome". Arch. Intern. Med. 148 (7): 1633–6. PMID 3382309.
  4. ↑ Cappelli S, Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radić M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirják L, Damjanov N, Rednic S, Matucci Cerinic M (2012). ""To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity". Semin. Arthritis Rheum. 41 (4): 589–98. doi:10.1016/j.semarthrit.2011.07.010. PMID 21959290.
  5. ↑ Alarcón GS, Williams GV, Singer JZ, Steen VD, Clegg DO, Paulus HE, Billingsley LM, Luggen ME, Polisson RP, Willkens RF (1991). "Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease". J. Rheumatol. 18 (9): 1332–9. PMID 1757934.
  6. ↑ LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F (1988). "Scleroderma (systemic sclerosis): classification, subsets and pathogenesis". J. Rheumatol. 15 (2): 202–5. PMID 3361530.
  7. ↑ Roguedas AM, Misery L, Sassolas B, Le Masson G, Pennec YL, Youinou P (2004). "Cutaneous manifestations of primary Sjögren's syndrome are underestimated". Clin. Exp. Rheumatol. 22 (5): 632–6. PMID 15485020.
  8. ↑ Bablekos GD, Michaelides SA, Karachalios GN, Nicolaou IN, Batistatou AK, Charalabopoulos KA (2006). "Pericardial involvement as an atypical manifestation of giant cell arteritis: report of a clinical case and literature review". Am. J. Med. Sci. 332 (4): 198–204. PMID 17031245.
  9. ↑ Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE (1977). "Takayasu's arteritis. Clinical study of 107 cases". Am. Heart J. 93 (1): 94–103. PMID 12655.
  10. ↑ Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, Bienvenu B, Mouthon L, Guillevin L (2010). "Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database". Arthritis Rheum. 62 (2): 616–26. doi:10.1002/art.27240. PMID 20112401.
  11. ↑ Tunç R, Uluhan A, Melikoğlu M, Ozyazgan Y, Ozdoğan H, Yazici H (2001). "A reassessment of the International Study Group criteria for the diagnosis (classification) of Behçet's syndrome". Clin. Exp. Rheumatol. 19 (5 Suppl 24): S45–7. PMID 11760398.
  12. ↑ Kucukardali Y, Solmazgul E, Kunter E, Oncul O, Yildirim S, Kaplan M (2007). "Kikuchi-Fujimoto Disease: analysis of 244 cases". Clin. Rheumatol. 26 (1): 50–4. doi:10.1007/s10067-006-0230-5. PMID 16538388.
  13. ↑ Kunnamo I, Kallio P, Pelkonen P, Viander M (1986). "Serum-sickness-like disease is a common cause of acute arthritis in children". Acta Paediatr Scand. 75 (6): 964–9. PMID 3564980.
  14. ↑ Oriente P, Biondi-Oriente C, Scarpa R (1994). "Psoriatic arthritis. Clinical manifestations". Baillieres Clin Rheumatol. 8 (2): 277–94. PMID 8076388.
  15. ↑ Kaufmann J, Buccola JM, Stead W, Rowley C, Wong M, Bates CK (2007). "Secondary symptomatic parvovirus B19 infection in a healthy adult". J Gen Intern Med. 22 (6): 877–8. doi:10.1007/s11606-007-0173-9. PMC 2219874. PMID 17384979.
Retrieved from "https://www.wikidoc.org/index.php?title=Differentiating_systemic_lupus_erythematosus_from_other_diseases&oldid=1552966"